TRCT
RNVA

Tower Research Capital (TRC)’s Rennova Health, Inc. RNVA Stock Holding History

Tower Research Capital (TRC)’s Portfolio RNVA Stock Details RNVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1
Closed – – 5388
2016
Q1 		$0 Hold
1
– – ﹤0.01% 5489
2015
Q4 		$1K Buy
+1
New +$1.73K ﹤0.01% 4295
2014
Q3 		– Hold
0
– -$2K – 5200
2014
Q2 		– Hold
0
– – – 3534
2014
Q1 		– Hold
0
– – – 3986
2013
Q4 		– Sell
-1
Closed -$12K – 5200
2013
Q3 		$12K Buy
+1
New +$16.9K ﹤0.01% 3109

Other funds holding RNVA

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC)'s RNVA Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of Rennova Health, Inc. (RNVA) in Q2 2016, closing a stake of 1 share.

Tower Research Capital (TRC) first reported a position in RNVA in Q3 2013 and held it in 3 quarters. The position peaked at $12K in Q3 2013. 9 funds tracked by Wall St. Rank hold RNVA as of Q2 2016.

  • Tower Research Capital (TRC) reported no remaining Rennova Health, Inc. position as of Q2 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1 Rennova Health, Inc. share in Q2 2016.
  • Tower Research Capital (TRC) first reported a position in Rennova Health, Inc. in Q3 2013 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Rennova Health, Inc. position peaked at $12K in Q3 2013.
  • 9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.